Bile Duct Neoplasms Clinical Trial
Official title:
Covered and Uncovered Self Expandable Metallic Stents Are Equally Efficacious in Bile Duct Strictures. Results of a Randomized Study.
The study is investigator initiated. Tumors that gives the narrowing of the bile ducts
prevents bile from flowing from the liver to the intestine resulting in jaundice and the
risk of bacterial growth in bile with severe infections as a result. Unresectable bile duct
strictures have routinely been treated them with plastic stents. The plastic stents have
been replaced by self expandable metallic stents.
These stents remain open longer for reasons that they have a larger diameter so that the
bile flows through more easily. One problem with these stents, however, is that the tumor
growing through the wire mesh which forms the wall of the stent. This has led to the
development of so-called covered stents. Whether covered stents have longer patency is
unclear as well as whether they are as safe. There is reason to believe that covered stents
remain open longer, but there may be an increased risk of migration and other complications.
The purpose is to prospectively and randomized compare the two stent types. The study
endpoint is the clogging of the stent or the patient's death. We also monitor complications,
regress time of the jaundice and success rate of stent placement
0 ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05600803 -
Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions
|
||
Recruiting |
NCT05286814 -
M9241 in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma
|
Phase 2 | |
Recruiting |
NCT06115655 -
A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation Profiles
|
||
Enrolling by invitation |
NCT03951324 -
Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study
|
||
Active, not recruiting |
NCT05374122 -
AI Guidance for Biopsy in Suspected Cholangiocarcinoma
|
N/A | |
Terminated |
NCT04276090 -
Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma
|
N/A | |
Active, not recruiting |
NCT00582647 -
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
|
||
Recruiting |
NCT00915863 -
Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy
|
N/A | |
Recruiting |
NCT05172310 -
PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
|
Phase 1 | |
Recruiting |
NCT05320328 -
RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTION
|
||
Completed |
NCT01845337 -
Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine
|
Phase 2 | |
Completed |
NCT04847167 -
Mechanistic Loop Resolution Strategy for Short-type Single Balloon Enteroscopy
|
N/A | |
Completed |
NCT00634751 -
CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03838913 -
Whole-Exome Sequencing (WES) of Intraductal Neoplasms of the Bile Duct (IPNB)
|